|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||3.5000 - 3.6300|
|52 Week Range||1.9200 - 8.5000|
|Beta (3Y Monthly)||8.64|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
While stocks have taken a beating due to trade concerns with China and rising rates, there is green at the end of the tunnel! With Congress approving the 2018 Farm Bill, stocks in the CBD space are poised to benefit and should run counter to the current market downward trends. The passage of the 2018 Farm Bill presents a tremendous opportunity for the CBD sector to continue to grow while the rest of the market shows significant volatility. Cannabidiol, or CBD, is the non-psychoactive chemical compound found in the hemp plant.
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at the growing opportunity in the sector with the expected imminent passing of the US 2018 Farm Bill. Cabot Wealth said last week in an article, What the Farm Bill Means for Cannabis Stocks, “If the Farm Bill passes with hemp legalization intact, it could herald boom times for the CBD industry, with giant retail players like Walgreens and CVS and Walmart becoming the biggest retailers.
While stocks have taken a beating due to trade concerns with China and rising rates, there is green at the end of the tunnel! With the expected vote and passage of the 2018 Farm Bill on Monday, stocks that are in the CBD space are poised to benefit and should run counter to the current market downward trends. Stocks in the CBD and cannabis space have not been immune from the market’s downturn, but the expected passage of the bill should provide an opportunity to acquire high growth stocks in this bear market. The 2018 Farm Bill will nationally legalize the cultivation and farming of that plant.
MESQUITE, NV / ACCESSWIRE / October 25, 2018 / Cannabis Sativa, Inc. (CBDS) is pleased to announce that on October 23, 2018, the United States Patent Office issued US Patent number 10105343 titled “Cannabis based compositions and methods of treating hypertension” to Cannabis Sativa”. The marijuana lozenge invention relates to a Cannabis-based pharmaceutical composition for the treatment of hypertensive disorders by submucosal delivery comprising a pharmaceutically acceptable base and an effective amount of at least one cannabinoid or endocannabinoid containing extract of a cloned hybrid of the plant Cannabis sativa, subspecies sativa and Cannabis sativa, subspecies indica of the CTSX-ISS lineage. “CBDS acquired the rights to certain pending IP in a stock based, multimillion dollar agreement in 2014”, said President David Tobias.
MESQUITE, NV / ACCESSWIRE / October 15, 2018 / Cannabis Sativa, Inc. (CBDS) is pleased to announce that the United States Patent Office will issue to CBDS the US Patent number 10105343 titled "Cannabis based compositions and methods of treating hypertension" on October 23, 2018. "Cannabis Sativa made a bold deal acquiring this pending IP in the merger acquisition of Kush in 2014, which included Kubby Patent and Licenses. "This coconut oil based lozenge is unique because of its rapid onset and long term effects, and is based on our patented strain of cannabis, Ecuadorian Sativa", stated President David Tobias.
MESQUITE, NV / ACCESSWIRE / September 25, 2018 / Cannabis Sativa, Inc. (CBDS) subsidiary PrestoDoctor is pleased to announce that it is currently providing online medical marijuana recommendations to Pennsylvania residents via its HIPPA compliant trusted online recommendation platform https://Prestodoctor.Com/. PrestoDoctor makes the process simple and seamless by providing the state required two doctor appointments completely online, allowing patients to speak to licensed compassionate physicians who specialize in medical marijuana evaluations. Post appointment, PrestoDoctor provides patients all the necessary instructions on registering with the state in a comprehensive email.
NEW YORK, NY / ACCESSWIRE / September 18, 2018 / U.S. equities retreated from records Monday as President Donald Trump plans to announce an additional $200 billion in tariffs on Chinese products. The Dow ...
MESQUITE, NV / ACCESSWIRE / September 12, 2018 / Cannabis Sativa, Inc. (CBDS) is pleased to announce that Debby Goldsberry, a member of the Cannabis Sativa Board of Directors, tops the High Times list of their first ever 'Women in Weed'' themed issue. Debby Goldsberry was lauded as an advocate and owner operator of Magnolia Oakland Dispensary. ''We congratulate Debby Goldsberry for her well-deserved top placement,'' said CEO and former Senator Mike Gravel, ''I am proud to have motivated Debby to come aboard Cannabis Sativa.
MESQUITE, NV / ACCESSWIRE / April 5, 2018 / Cannabis Sativa, Inc. (OTCQB: CBDS) is pleased to announce that PrestoDoctor®, the leading online medical marijuana recommendation service, will be expanding ...